Loading market dashboard
Merrimack Pharmaceuticals, Inc.
MACKHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Merrimack Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2018 | $11.50M | $11.50M - $11.50M | -$100.70M | -$3.19 | 1 |
| Dec 2017 | $33.00M | $33.00M - $33.00M | $0.00 | $36.279 | 1 |
| Dec 2016 | $136.85M | $136.85M - $136.85M | $0.00 | -$11.55 | 1 |
| Dec 2015 | $84.53M | $84.53M - $84.53M | -$116.15M | -$11.767 | 8 |
| Dec 2014 | $160.91M | $128.73M - $193.09M | -$67.25M | -$7.44 | 14 |
| Dec 2013 | $42.76M | $34.21M - $51.31M | -$99.48M | -$9.82 | 8 |